author-photo

Marina Parisi

University of Catania

25

Papers

95

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Lenalidomide and Pomalidomide Improve Function and Induce FcγRI/CD64 in Multiple Myeloma Neutrophils.

2021 Biomedicines
Show All
- Source
- Cite
- Save
Citations (0)
Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association

2021 Hematology Reviews
Show All
- Source
- Cite
- Save
Citations (0)
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database

2021 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents

2020 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (2)
EARLY SALVAGE TREATMENT WITH SECOND-GENERATION NOVEL AGENTS AT BIOCHEMICAL RELAPSE PROLONGS OVERALL SURVIVAL: A REAL-WORLD SINGLE CENTER EXPERIENCE: PF632

2019
Show All
- Source
- Cite
- Save
Citations (0)
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

2019 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (16)
CLINICAL BENEFIT OF LONG-TERM DISEASE CONTROL WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: PB2128

2019
Show All
- Source
- Cite
- Save
Citations (1)
LONG TERM FOLLOW-UP OF WALDENSTRÖM MACROGLOBULINEMIA PATIENTS PRIMARY TREATED WITH DEXAMETHASONE, RITUXIMAB, AND CYCLOPHOSPHAMIDE: A SINGLE CENTRE EXPERIENCE: PS1318

2019
Show All
- Source
- Cite
- Save
Citations (0)
FEASIBILITY, TOLERABILITY AND EFFICACY OF CARFILZOMIB, LENALIDOMIDE AND DESAMETHASONE(KRD) IN RELAPSED REFRACTORY MYELOMA PATIENTS: A REAL-LIFE SURVEY OF THE SICILIAN MYELOMA NETWORK: PB2123

2019
Show All
- Source
- Cite
- Save
Citations (0)